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A B S T R A C T
The effects of anaesthetic agents on brain energy metabolism may explain their shared neurophysiological ac-
tions but remain poorly understood. The brain lactate shuttle hypothesis proposes that lactate, provided by
astrocytes, is an important neuronal energy substrate. Here we tested the hypothesis that anaesthetic agents
impair the brain lactate shuttle by interfering with astrocytic glycolysis. Lactate biosensors were used to record
changes in lactate release by adult rat brainstem and cortical slices in response to thiopental, propofol and
etomidate. Changes in cytosolic nicotinamide adenine dinucleotide reduced (NADH) and oxidized (NAD+) ratio
as a measure of glycolytic rate were recorded in cultured astrocytes. It was found that in brainstem slices
thiopental, propofol and etomidate reduced lactate release by 7.4 ± 3.6% (P < 0.001), 9.7 ± 6.6%
(P < 0.001) and 8.0 ± 7.8% (P = 0.04), respectively. In cortical slices, thiopental reduced lactate release by
8.2 ± 5.6% (P = 0.002) and propofol by 6.0 ± 4.5% (P = 0.009). Lactate release in cortical slices measured
during the light phase (period of sleep/low activity) was ~25% lower than that measured during the dark phase
(period of wakefulness) (326 ± 83 μM vs 430 ± 118 μM, n = 10; P = 0.04). Thiopental and etomidate
induced proportionally similar decreases in cytosolic [NADH]:[NAD+] ratio in astrocytes, indicative of a re-
duction in glycolytic rate. These data suggest that anaesthetic agents inhibit astrocytic glycolysis and reduce the
level of extracellular lactate in the brain. Similar reductions in brain lactate release occur during natural state of
sleep, suggesting that general anaesthesia may recapitulate some of the effects of sleep on brain energy meta-
bolism.
1. Introduction
Anaesthetic agents induce a reversible state of unconsciousness by
altering the neuronal activity through enhancing inhibitory, and/or
inhibiting excitatory synaptic interactions (Garcia et al., 2010). Many
injectable anaesthetics, including propofol (fast-acting nonbarbiturate),
etomidate (nonbarbiturate imidazolic derivative), and thiopental (bar-
biturate) share a common mechanism of action by enhancing the effi-
cacy of signalling via the inhibitory gamma-aminobutyric acid A
(GABAA) receptors (Canbek et al., 2015). Anaesthesia and sleep may
share some common neurophysiological mechanisms (Vacas et al.,
2013), including suppression of arousal via enhanced activity of GA-
BAergic pathways (Lu et al., 2008). For example, in brain regions that
promote wakefulness, such as dorsal raphé, hypothalamic tuber-
omammillary nucleus, medial preoptic area and others, facilitated
GABAergic inhibition has been shown to promote sleep, – an effect
similar to that of anaesthetic agents that target GABAA receptor-medi-
ated mechanisms (Watson et al., 2010).
CNS neurons require a constant energy supply that matches their
high metabolic demands. According to the astrocyte-to-neuron lactate
shuttle hypothesis, lactate is a major neuronal energy substrate
(Pellerin et al., 1998). Lactate is supplied to neurons by neighbouring
astrocytes following glycolytic breakdown of glucose and release via
monocarboxylate transporters (MCTs) (Perez-Escuredo et al., 2016)
and/or certain membrane channels (Sotelo-Hitschfeld et al., 2015;
Karagiannis et al., 2016; Hadjihambi et al., 2017). There is evidence
that reduced glucose metabolism in astrocytes delays emergence from
general anaesthesia (Ramadasan-Nair et al., 2019). However, the effects
of general anaesthesia on brain energy metabolism are poorly under-
stood. Changes in cerebral blood flow and cerebral metabolic rate of
oxygen have been reported with the use of propofol (Kaisti et al., 2003),
etomidate (Cold et al., 1985) and thiopental (Wechsler et al., 1951).
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Limited data exists on the effects of anaesthetic agents on brain lactate
metabolism. A microdialysis study (Horn and Klein, 2010) reported an
increase in lactate concentration in the mouse brain upon exposure to
isoflurane. By contrast, results of another study that used 13C-magnetic
resonance spectroscopy suggested that cortical rates of oxidative me-
tabolism in both glia and neurons are reduced under thiopental an-
aesthesia (Sonnay et al., 2017). The authors of the latter report pro-
posed that lactate is used as a substitute metabolic substrate upon
exposure to this anaesthetic agent (Sonnay et al., 2017).
This study tested the hypothesis that anaesthetic agents exert their
effects, at least in part, through the inhibition of the astrocyte-to-neuron
lactate shuttle. The data obtained show that propofol, etomidate and
thiopental reduce the release of lactate in the brain. The effects are
similar to that of a naturally occurring state of sleep, suggesting that
general anaesthesia may recapitulate some of the effects of sleep on
brain energy metabolism.
2. Materials & methods
All experiments were performed in accordance with the European
Commission Directive 2010/63 (European Convention for the
Protection of Vertebrate Animals used for Experimental and Other
Scientific Purposes) and the UK Home Office (Scientific Procedures) Act
(1986) with project approval by the Institutional Animal Welfare and
Ethical Review Committee of the University College London (Ref
PECE77103). ARRIVE guidelines were adhered to.
2.1. Slice preparation
Young adult male Sprague-Dawley rats (~200 g, n = 100), supplied
by the University College London animal facility were group housed (3
per cage) in individually ventilated cages kept on a 12 h light-dark cycle
(light 07:00-19:00), with ad libitum access to standard rat chow and
water. Environmental enrichment was provided in the form of chew
sticks and cardboard tubes. In the laboratory, the animals were term-
inally anesthetized with halothane inhalation overdose and the brains
were removed and placed in ice cold artificial cerebrospinal fluid
(aCSF) containing 124 mM NaCl, 26 mM NaHCO3, 3 mM KCl, 2 mM
CaCl2, 1.25 mM NaH2PO4, 1 mMMgSO4, 10 mM Glucose saturated with
95% O2 and 5% CO2 (pH 7.4) with an addition of 9 mM Mg2+. Coronal
cortical (cut at the level of the somatosensory cortex) and brainstem
slices (thickness 300 μm) were prepared using a vibratome and then
incubated at room temperature for 1 h in a standard aCSF saturated
with 95% O2 and 5% CO2.
2.2. Recording lactate release
Recordings were made from the brain slices placed on an elevated
grid in a flow chamber (flow 3 ml/min) at 35°C. Release of lactate was
recoded in real-time using amperometric enzymatic lactate biosensors
(Sarissa Biomedical) placed in a direct contact with the surface of the
slice (Fig. 1A). The operation of the lactate biosensor is based on the
enzymatic activity of lactate oxidase which, in the presence of oxygen,
converts lactate to pyruvate and H2O2. The latter is detected electro-
chemically. A dual recording configuration of a null sensor (lacking
lactate oxidase) placed on the surface of the slice along the lactate
biosensor was used, as described in detail previously (Gourine et al.,
2005, 2008; Karagiannis et al., 2016; Hadjihambi et al., 2017)
(Fig. 1A). The null sensor was used to control for the potential release of
non-specific electroactive interferents that could confound the mea-
surements. Null sensor currents were subtracted from the lactate bio-
sensor currents. Biosensors were calibrated directly in the recording
chamber immediately before and after every recording by application
of 100 μM lactate (Fig. 1C). The initial and final calibrations were used
to determine the sensor sensitivity changes during the experiment. The
sensor currents were converted to lactate concentrations according to
this calibration (Fig. 1C).
To determine the differences in brain lactate release between sleep
and wakefulness, the rats were killed, and cortical slices were prepared
either during the dark phase (wakefulness) or light phase (sleep/low
activity) of the 24 h light-dark cycle. The experiments were performed
between 12:00-16:00 for the light phase (lights on 07:00-19:00) or
00:00-06:00 for the dark phase (lights off 19:00-07:00). All the ex-
periments involving testing the effects of the drugs on tonic lactate
release were performed between 12:00-16:00.
2.3. Primary astrocyte cultures
Primary astrocyte cultures were prepared from the brains of rat
pups (p2-p5 of either sex) as described previously (Theparambil et al.,
2014; Turovsky et al., 2016; Sheikhbahaei et al., 2018). After isolation,
the cells were plated on Poly-L-Lysine coated glass coverslips (15 mm)
and maintained in Dulbecco's Modified Eagle's Medium (DMEM) con-
taining 5% fetal calf serum in a humidified atmosphere of 5% CO2 and
95% air at 37°C. The culture medium was replaced after 24 h of cell
plating and subsequently every 3 days.
2.4. Recording changes in cytosolic nicotinamide adenine dinucleotide
(reduced, NADH; oxidized, NAD+) [NADH]:[NAD+] ratio is astrocytes
After 7 days of culturing, astrocytes were transduced to express a
genetically-encoded [NADH]/[NAD+] sensor Peredox using an adeno-
viral vector AVV-CMV-Peredox (Hung et al., 2011). The cells were used
for imaging experiments after 3 days of the transfection. Recordings
were made in aCSF in a flow chamber (flow 1 ml/min) at 35°C. An
Olympus IX71×inverted microscope, 20x oil immersion objective lens,
cooled CCD camera (Clara, Andor) and Andor iQ3 software were used
for data acquisition. The green T-Sapphire and red mCherry proteins
were alternatively excited using 405/10 nm and 575/10 nm wave-
lengths at a frequency of 0.2 Hz. The fluorescence emission was re-
corded at 535/30 nm and 632/60 nm.
2.5. Drugs
Once the biosensor recordings of tonic lactate release or Peredox
fluorescence emission had stabilized (~15 min), anaesthetic agents
were bath applied and the changes in the release of lactate or cytosolic
[NADH]:[NAD+] ratio were recorded. Muscimol was applied at a
concentration of 100 μM (Cheung et al., 2009). Propofol, thiopental and
etomidate were applied at 10 μM. Propofol was obtained from Aspen
Pharma. All other drugs were obtained from Sigma, diluted in the sol-
vent suggested by the supplier and added to the perfusate at the in-
dicated concentration.
2.6. Statistical analysis
Lactate biosensor recordings were processed using Power 1401 in-
terface and analysed using Spike 2 software (Cambridge Electronic
Design) and Prism software (GraphPad 7.0). Based on our data obtained
previously with the use of amperometric biosensors, a sample size of at
least 10 was calculated to give 90% power (alpha = 0.05) (Gpower
3 v3.1.9.2). Data are reported as individual data points and box and
whisker plots. Datasets were tested for normality and were compared
using paired samples Wilcoxon Signed Ranks Test or Student's paired or
unpaired t-test, as appropriate. The results of the imaging experiments
are reported as bar charts and the group data were compared using
Student's paired t-test. Values in the text are expressed as means ± S.D.
Differences between the experimental groups with P values of less than
0.05 were considered to be significant. All reported n numbers indicate
the numbers of animals.
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3. Results
The lactate biosensors were placed either across all the layers of the
cortex or close to the ventral surface of the brainstem (Fig. 1A). Sig-
nificant tonic lactate release (lactate tone) was detected by the bio-
sensors at the surface of the brainstem (357 ± 131 μM; n = 43,
P < 0.001) and cortical (350 ± 122 μM; n = 37, P < 0.001) slices
(Fig. 1B). Once the measurement of tonic lactate release had stabilized,
anaesthetic agents were applied and the changes in the release of lac-
tate were recorded (Fig. 1C). In brainstem slices, thiopental (10 μM),
propofol (10 μM) and etomidate (10 μM) had similar effects and re-
duced the release of lactate by 7.4 ± 3.6% (n = 13, P < 0.001),
9.7 ± 6.6% (n = 12, P < 0.001) and 8.0 ± 7.8% (n = 9, P = 0.04),
respectively (Fig. 2). In cortical slices, thiopental and propofol reduced
lactate release by 8.2 ± 5.6% (n = 11, P = 0.002) and 6.0 ± 4.5%
(n = 8, P = 0.009), respectively (Fig. 3). Etomidate in the con-
centration used (10 μM) had no effect on tonic lactate release recorded
in the cortical slices (2.8 ± 6.8%; n = 18, P = 0.09) (Fig. 3). Mus-
cimol, a potent GABAA agonist, applied in concentration 100 μM had no
effect on brain lactate release (0.9 ± 4.5%; n = 8, P = 0.5) (Fig. 2).
There is significant evidence that astrocytes (as highly glycolytic
cells) are the net produces of lactate that is transported to neurons in
accord with the concentration gradient of this metabolite (Machler
et al., 2016; Barros and Weber, 2018). High cytosolic [NADH]:[NAD+]
ratio in astrocytes is primarily conferred by glycolysis (Hung et al.,
2011; Kohler et al., 2018), therefore, it can be used as a measure of
glycolytic rate (Hung et al., 2011). It was found that both thiopental
(P< 0.001) and etomidate (P<0.001) reversibly decreased the cyto-
solic [NADH]:[NAD+] ratio in astrocytes (Fig 4A, C), indicating that
these agents reduce the glycolytic rate. The effect of propofol was not
tested because the optical properties of propofol solution interfered
with the measurements of changes in Peredox fluorescence. Muscimol
had no effect on cytosolic [NADH]:[NAD+] ratio in astrocytes (P = 0.3,
Fig. 1. Biosensor recordings of lactate release in
cortical and brainstem slices. A) Schematic draw-
ings of the dual recording configuration of lactate
and null (control) biosensors placed on the surfaces
of cortical and brainstem slices. B) Summary data
illustrating tonic lactate release (lactate tone) re-
corded in 43 brainstem and 37 cortical slices. C)
Representative example of changes in the net lactate
biosensor current (difference in current between the
lactate and null sensors) during calibration (100 μM
lactate), after biosensor placement in the direct
contact with the surface of the cortical slice (re-
cording tonic lactate release) and in response to ap-
plication of thiopental (10 μM).
Fig. 2. Changes in lactate release recorded in brainstem slices in response
to the anaesthetic agents. A) Representative recordings of lactate biosensor
currents showing changes in tonic lactate release in response to test drugs.
Dashed lines show the extrapolation of lactate biosensor current prior to the
application of the drug. B) Summary data illustrating the magnitude of changes
in tonic lactate release in response to application of muscimol (100 μM), pro-
pofol (10 μM), thiopental (10 μM) or etomidate (10 μM).
Fig. 3. Changes in lactate release recorded in cortical slices in response to
the anaesthetic agents. A) Representative recordings of lactate biosensor
currents showing changes in tonic lactate release in response to test drugs.
Dashed lines show the extrapolation of lactate biosensor current prior to the
application of the drug. B) Summary data illustrating the magnitude of changes
in tonic lactate release in response to application of propofol (10 μM), thio-
pental (10 μM) or etomidate (10 μM).
A. Hadjihambi, et al. European Journal of Pharmacology 881 (2020) 173188
3
Fig. 4A, C). Changes in [NADH]:[NAD+] ratio in astrocytes induced by
anaesthetic agents were compared to that induced by glucose depri-
vation (0 mM glucose in aCSF) or irreversible inhibition of glycolysis
with iodoacetic acid (IAA, 1 mM). Both glucose deprivation (P<0.001)
and IAA (P<0.001) caused marked reductions in cytosolic [NADH]:
[NAD+] ratio (Fig. 4B, C). The effect of thiopental on [NADH]:[NAD+]
ratio in astrocytes was calculated to be 7% of that induced by glucose
deprivation and 10% of that induced by IAA. The inhibitory effect of
etomidate on astrocytic glycolysis was 13% of that induced by glucose
deprivation and 19% of that induced by IAA.
The effects of anaesthetic agents on brain lactate release were next
compared to that occurring naturally during the transition from wa-
kefulness to sleep. It was found that tonic lactate release in cortical
slices of animals killed during the light phase (period of sleep/low ac-
tivity) was ~25% lower than that of animals killed during the dark
phase (period of wakefulness) (326 ± 83 μM, n = 10 vs
430 ± 118 μM, n = 10; P = 0.04) (Fig. 5).
4. Discussion
The effects of general anaesthesia on brain energy metabolism re-
main incompletely understood. Although several studies investigated
the effects of anaesthetic agents on brain metabolism (Horn and Klein,
2010; Liu et al., 2016; Sonnay et al., 2017), most of the data appear to
be inconclusive or conflicting, likely due to the distinct CNS targets of
different anaesthetic agents (Sonner et al., 2003; Forman and Chin,
2008). Moreover, while there is an ongoing debate on whether the state
of general anaesthesia resembles natural sleep (Vacas et al., 2013),
changes in brain energy metabolism under general anaesthesia and
sleep have not been comparatively assessed.
This study tested the hypothesis that anaesthetic agents may act via
the impairment of the astrocyte-to-neuron lactate shuttle and, by doing
so, reduce supply of energy substrate(s) to the CNS neurons and lower
the brain activity. We selected three anaesthetic agents, propofol,
thiopental and etomidate, all known to facilitate signalling mediated by
GABAergic mechanisms, and investigated the effects of these agents on
lactate release by the cerebral cortex and the brainstem. Experiments
were conducted in acute brain slices to exclude the systemic effects of
the drugs. The chosen concentrations of propofol and etomidate (both
at 10 μM) were considered to be clinically relevant based on the results
of published studies that investigated the diffusion characteristics and
potencies of these drugs (Benkwitz et al., 2007). With 10 μM of eto-
midate, slice tissue concentration of ≥4 μM is expected to be reached
during the application period (Voss et al., 2016), which is within the
range (4-12 μM) required to induce a state of deep anaesthesia in ex-
perimental animals (De Paepe et al., 1999). Clinical concentrations of
thiopental range between 10 and 100 μM (Pryor et al., 2004; Veselis
et al., 2004; Papatheodoropoulos et al., 2007). The use of 10 μM thio-
pental was selected because when this concentration in the brain is
reached, the experimental animals lose their righting reflex (Gustafsson
et al., 1996) and humans fail to respond to verbal commands (Hung
et al., 1992). There is also evidence that thiopental in this concentration
prolongs postsynaptic inhibitory currents (Dickinson et al., 2002), and
reduces the efficacy of gap junction-mediated signalling (Wentlandt
et al., 2006).
The data obtained showed that propofol, thiopental and etomidate
reduce the release of lactate in the brain. The application of a potent
GABAA receptor agonist muscimol had no effect, suggesting that the
decreases in lactate release in response to these anaesthetic agents are
not due to the actions of these agents on GABAA receptor-mediated
mechanisms.
According to the results of earlier studies using the same lactate
biosensors (Karagiannis et al., 2016), lactate tone recorded on the intact
(uncut) brainstem surface was similar to that measured by the bio-
sensors placed in a direct contact with the surface of the coronal brain
sections. The same study reported that lactate tone detected on the slice
surface was markedly and reversibly reduced by application of the
lactate dehydrogenase inhibitor oxamate (Karagiannis et al., 2016).
These data confirmed the analyte selectivity of the lactate biosensor
detection system and indicated that the damaged/dying cells are not
the primary source of lactate release in this preparation.
While general anaesthesia is usually described as a “reversible drug-
induced coma”, rather than deep sleep (Brown et al., 2010), a study by
Thrane et al. (2012) demonstrated in rodents that different anaesthetic
agents induce electrocorticogram activity changes closely resembling
those occurring during sleep. The data obtained in our study showed
Fig. 4. Changes in cytosolic [NADH]:[NAD+]
ratio in cultured astrocytes in response to the
anaesthetic agents. A) Representative recordings of
Peredox fluorescence changes illustrating the effect
of thiopental (10 μM), etomidate (10 μM) and mus-
cimol (100 μM) on cytosolic [NADH]:[NAD+] ratio
in cultured astrocytes. Dashed lines show the extra-
polation of the Peredox fluorescence prior to the
application of the test drug. B) Representative re-
cordings of Peredox fluorescence changes illustrating
the effect of 0 mM glucose and iodoacetic acid (IAA,
irreversible inhibitor of glycolysis) on cytosolic
[NADH]:[NAD+] ratio. Dashed lines show the ex-
trapolation of the baseline Peredox fluorescence. C)
Summary data illustrating the effects of thiopental,
etomidate, muscimol, glucose deprivation and IAA
on cytosolic [NADH]:[NAD+] ratio in cultured as-
trocytes.
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that tonic lactate release in cortical slices of animals killed during the
light phase (period of sleep/low activity) was lower than that of ani-
mals killed during the dark phase (period of wakefulness). Therefore,
the effects of anaesthetics on extracellular lactate in the brain resemble
changes induced by a natural state of sleep and may suggest the ex-
istence of some common underlying mechanisms.
That the brain lactate concentration is higher during wakefulness
than during sleep has been reported previously (Shram et al., 2002;
Naylor et al., 2012; Lundgaard et al., 2017). Shram and colleagues
(Shram et al., 2002) observed a 16% reduction of brain lactate con-
centration during slow wave sleep in freely behaving rats. Lundgaard
et al. (2017) reported a 20-30% reduction in cortical extracellular
lactate during transition from the dark phase to light phase in mice, the
effect that the authors explained by enhanced lactate clearance via the
glymphatic system during sleep. In this study we observed quantitively
similar (~25%) reduction of tonic lactate release recorded in cortical
slices prepared from the brains of animals during their period of sleep/
low activity, the difference that cannot be explained by facilitated
clearance via convective flow and fluid exchange.
Measurements of cytosolic [NADH]:[NAD+] ratio in astrocytes de-
monstrated that thiopental and etomidate have a direct effect on these
cells and inhibit astrocytic glycolytic rate. These data suggest that an-
aesthetic agents decrease brain extracellular lactate concentration by
interfering with glucose metabolism in astrocytes. However, we cannot
exclude the possibility that anaesthetics may also have an effect on the
mechanisms of lactate release that involve MCTs (Perez-Escuredo et al.,
2016) and/or membrane channels, including connexin and pannexin
hemichannels (Sotelo-Hitschfeld et al., 2015; Karagiannis et al., 2016).
Indeed, there is evidence (Wentlandt et al., 2006) that some anaesthetic
agents inhibit gap junctions and gap junction hemichannels expressed
by astrocytes and neurons. We previously reported that hemichannels
function as conduits of lactate release (Karagiannis et al., 2016), sup-
porting the hypothesis that anaesthetic agents may also act through
inhibition of hemichannel activity. This hypothesis is also supported by
the evidence of a significant concentration gradient between astrocytes
and neurons that favours astrocyte-to-neuron flow of lactate (Machler
et al., 2016).
This study aimed to address the effect of general anaesthesia on
brain energy metabolism focusing on astrocytes as the major source of
lactate, highlighted in the recent editorial (Perouansky et al., 2019).
The strength of this study is that different agents were used and showed
similar effects on brain lactate release and astrocytic glycolysis. Our
experiments focused on the glycolytic aspect of brain energy metabo-
lism and more specifically on the supply of lactate by astrocytes to
support the metabolic needs of active neurons, which compliment re-
cently published works in the field (Ramadasan-Nair et al., 2019). In
addition, changes in brain lactate release under anaesthesia and sleep
have been comparatively assessed. An additional strength of this study
is that the experiments were conducted in vitro and the effects of an-
aesthetic agents on brain tissue lactate release were not confounded by
systemic effects or the effects of these drugs on the efficacy of lactate
clearance by the brain fluid exchange mechanisms (Lundgaard et al.,
2017). The use of slice specific calibrations allowed comparisons of the
effects between different experimental conditions.
5. Conclusions
In conclusion, the results of this study demonstrate that anaesthetic
agents inhibit astrocytic glycolysis and reduce the level of extracellular
lactate in the brain. These effects are similar to that of a naturally oc-
curring state of sleep, suggesting that general anaesthesia may re-
capitulate some of the effects of sleep on brain energy metabolism.
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